Evidence map›Paper›PMID 40766228›Full record

ArticleResearch square2025

Cross-level Cross-Scale Inference and Imputation of Single-cell Spatial Proteomics.

You Wu, Lei Xie

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

You WuPh.D. Program in Computer Science, The Graduate Center, The City University of New York, New York, New York, USA.ORCID https://orcid.org/0000-0003-4807-8504
Lei XiePh.D. Program in Computer Science, The Graduate Center, The City University of New York, New York, New York, USA.ORCID https://orcid.org/0000-0001-9051-2111

Funding

Drug repurposing for Alzheimer's disease using structural systems pharmacology.R01AG057555 · NIA · NORTHEASTERN UNIVERSITY · PI Lei Xie · 2018 to 2026
$6.7M
Omics data integration and analysis for structure-based multi-target drug designR01GM122845 · NIGMS · NORTHEASTERN UNIVERSITY · PI Lei Xie · 2017 to 2026
$3.0M
AI-powered cross-level cross-species omics data integration to elucidate mechanisms of ELR21AG083302 · NIA · HUNTER COLLEGE · PI MELENDEZ, ALICIA, XIE, LEI · 2023 to 2023
$459k
NIA NIH HHS R01 AG057555NIA NIH HHS R21 AG083302NIGMS NIH HHS R01 GM122845
6 · The paper itself

Abstract

High-throughput single-cell and spatial omics technologies have transformed biological research. Despite these advances, reliably identifying the molecular drivers and their interplays across biological levels and scales remains a significant challenge. Current experimental methods are limited by batch effects, the lack of simultaneous multi-modal measurements in individual cells, limited coverage of measured proteins, poor generalization to unseen conditions, and insufficient spatial context at a single-cell resolution. To overcome these challenges, we introduce scProSpatial, a unified, multi-modal, multi-scale deep learning framework designed to infer and impute high fidelity single-cell spatial proteomics from scRNA-seqs. Through comprehensive evaluations, scProSpatial accurately predicts spatial abundances of proteins in the absence of shared transcriptomics features, expands protein coverages by 50 times, and generalizes robustly to out-of-distribution scenarios. A case study in metastatic breast cancer further illustrates its utility, demonstrating scProSpatial's potential to drive cross-level, cross-scale multi-omics integration and analysis and reveal deeper insights into complex biological systems.

Identifiers

PMID40766228
PMCPMC12324605

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.